grant

Aging and Estrogenic Control of the Bioenergetic System in Brain

Organization UNIVERSITY OF ARIZONALocation TUCSON, UNITED STATESPosted 15 Mar 2017Deadline 31 Mar 2027
NIHUS FederalResearch GrantFY2025AD dementiaAddressAgingAlzheimer Type DementiaAlzheimer disease dementiaAlzheimer sclerosisAlzheimer syndromeAlzheimer'sAlzheimer's DiseaseAlzheimers DementiaAquadiolBioenergeticsBrainBrain Nervous SystemCMKRL2Cell Communication and SignalingCell NucleusCell SignalingCell membraneCellular RegulationChemokine Receptor-Like 2ClinicalCytoplasmCytoplasmic MembraneD-GlucoseDataDextroseDimenformonDiogynDiogynetsDisseminated SclerosisER-BETAERalphaERbetaERαERβESR-BETAESR1ESR1 geneESR2ESR2 geneESRBESTRBElementsEncephalonEndocrine Gland SecretionEnergy ExpenditureEnergy MetabolismEstraceEstradiolEstradiol Receptor alphaEstradiol Receptor αEstradiol-17 betaEstradiol-17betaEstraldineEstrogen Receptor 1Estrogen Receptor 2Estrogen Receptor alphaEstrogen Receptor betaEstrogen Receptor αEstrogen Receptor βEstrogen ReceptorsEstrogen declineEstrogenic AgentsEstrogenic CompoundsEstrogensExpression SignatureFaceFeedbackFemaleFemale HealthFeminizationG Protein-Coupled Estrogen ReceptorG Protein-Coupled Receptor 30GPERGPER geneGPR30Gene ExpressionGene Expression ProfileGene TranscriptionGenerationsGenetic TranscriptionGenomicsGlucoseGoalsHormonesHumulin RIGF1IGF1 geneIGFIInsulinIntracellular Communication and SignalingIsoformsMenopauseMental DepressionMetabolicMitochondriaMonitorMultiple SclerosisNR3A1NR3A2Nerve CellsNerve UnitNervous System DiseasesNervous System DisorderNeural CellNeurocyteNeurologicNeurologic DisordersNeurologicalNeurological DisordersNeuronsNovolin RNuclearNucleusOutcomeOvocyclinOvocylinOxidation-ReductionPathway interactionsPatternPerformancePerimenopausalPerimenopausePlasma MembranePost-MenopausePost-Transcriptional ControlPost-Transcriptional RegulationPost-menopausal PeriodPostmenopausal PeriodPostmenopausePrevalencePrimary Senile Degenerative DementiaProcessProgynonProtein IsoformsPublic HealthRNA ExpressionRedoxRegular InsulinRegulationRegulatory PathwayResearchRespirationRiskRoleSeriesSignal TransductionSignal Transduction SystemsSignalingStarvationSystemSystems BiologyTestingTherapeutic EstradiolTherapeutic EstrogenTherapeutic HormoneTimeTranscriptionTranscriptional ControlTranscriptional RegulationWomanWomen's Healthafter menopauseage associatedage associated neurodegenerationage associated neurodegenerative diseaseage associated neurodegenerative disorderage correlatedage dependentage dependent neurodegenerationage dependent neurodegenerative conditionage dependent neurodegenerative diseaseage dependent neurodegenerative disorderage linkedage relatedage related neurodegenerationage specificage-driven neurodegenerative disordersage-related neurodegenerative diseaseage-related neurodegenerative disorderagedaged brainaged groupaged groupsaged individualaged individualsaged peopleaged personaged personsaged populationaged populationsaging associated neurodegenerationaging associated neurodegenerative diseaseaging brainaging populationaging related neurodegenerationaging related neurodegenerative diseaseaging related neurodegenerative disorderbiological signal transductionbrain controlcell growth regulationcell typeclinical significanceclinically significantdecline in estrogendecrease estrogendecrease in estrogendepressiondesigndesigningdisease riskdisorder riskestrogenicfacesfacialfollowing menopausefunctional outcomesgene expression patterngene expression signatureglucose metabolismglucose transportinsightinsular sclerosismenmenopause transitionmitochondrialmitochondrial genomeneurological diseaseneuronaloxidation reduction reactionpast menopausepathwayperi-menopausalperi-menopauseplasmalemmapopulation agingpost-menopausalpost-transcriptional gene regulationpostmenopausalpostmenopausal statusprimary degenerative dementiaprogramsreduced estrogenreproductiverespiratory mechanismresponsesenile dementia of the Alzheimer typesocial roletherapeutic targettranscriptional profiletranscriptional signaturetransition to menopausetransitional menopause
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Our earlier mechanistic analyses of estrogen action in brain led to the discovery that estrogen is a master
regulator of the bioenergetic system in brain that promotes glucose transport, glucose metabolism,

mitochondrial respiration and ATP generation. Collectively, the data provided compelling evidence for estrogen

as a systems biology metabolic regulator in brain and illuminated compensatory mechanisms consistent with

an aging female brain that is starving. For estrogen to function as master regulator of the bioenergetic system

in the female brain, estrogen must be integrating nuclear and mitochondrial genomic responses. Further from a

systems level perspective, it would be necessary for estrogen to also regulate cytoplasmic signaling

mechanisms for real time feedback on the functional outcomes of nuclear and mitochondrial gene transcription.

The fundamental issues to be investigated are the mechanisms whereby estrogen integrates bioenergetic

responses across two genomic compartments while simultaneously monitoring energetic demand and

performance in real time. The proposed program of research is designed to test two hypotheses. First,

estrogenic control of the bioenergetic system in the female brain requires: 1) both nuclear and mitochondrial

genomes; 2) integration of gene expression across both genomic compartments and 3) activation of rapid

signaling cascades to provide real time feedback on bioenergetic performance. Second, we hypothesize that

loss of estrogen in the aging female brain leads to a systematic dis-integration of estrogenic control of nuclear

and mitochondrial genomes followed by decline in bioenergetic sensing mechanisms. Estrogenic control of the

bioenergetic system of the brain and the dismantling thereof has basic, translational and clinical significance.

From a discovery perspective the proposed program of research is unique in exploring the mechanisms

underlying estrogenic integration of nuclear and mitochondrial gene expression and the real time feedback

mechanisms that control the bioenergetic system of the brain. Further, the process by which this control

system is dismantled in the aging female brain is uncharted territory of high significance for understanding

bioenergetic aging in brain. Translationally, determining the mechanisms underlying the systematic dismantling

of estrogenic integration of bioenergetic compartments in brain has the potential to detect therapeutic targets to

sustain bioenergetic function in the aging female brain. Clinically, the aging transition of menopause, unique to

the female, is a process that dismantles both reproductive ability and potentially bioenergetic capacity in brain.

This is particularly relevant to age-related neurological conditions associated with deficits in glucose

hypometabolism such as Alzheimer's, depression and multiple sclerosis which have greater prevalence in

postmenopausal women. Research proposed herein aligns with NIA Strategic Research Goals A and C and

the “need to better distinguish patterns of brain aging” https://www.nia.nih.gov/about/living-long-well-21st-

century-strategic-directions-research-aging and to objectives of Office of Research on Women's Health.

Grant Number: 5R37AG053589-09
NIH Institute/Center: NIH

Principal Investigator: ROBERTA BRINTON

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →